Before I even turned on my computer yesterday, the BBC had blared this headline about a trial of the protein interferon beta:The sub-headline read: The preliminary results of a clinical trial suggest a new treatment for Covid-19 reduces the number of patients needing intensive care, according to the UK company that developed it. Eventually some… Read More »
A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This: Ignore the CDC,” co-authored by former National Institutes of Health director Harold Varmus, was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More »
By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool A sign in Bolton, UK reminds people of the need for testingAdam Vaughan/Shutterstock Latest coronavirus news as of 5 pm on 5 October Nearly 16,000 coronavirus cases were missed in the UK due to a technical… Read More »
Thousands more people in England with type 2 diabetes will be offered the chance to try a soup-and-shake diet weight-loss plan for free on the NHS. Studies show switching to the low-calorie liquid diet can put diabetes into remission. Experts say they want to help people to be as fit as possible, particularly during the… Read More »
Getty Images For years, substances called tau protein or beta-amyloid have been theorized to be signs or causes of Alzheimer’s disease. There have been many reports of tests and treatments based on theories that tau and/or amyloid are at least signs, if not causes, of Alzheimer’s. Scientific uncertainty remains about the precise role of tau… Read More »